Abstract:We report the synthesis and evaluation of a series of cell-permeable and N- versus O-selective sialyltransferase inhibitors. Inhibitor design entailed the functionalization of lithocholic acid at C(3) and at the cyclopentane ring side chain. Among the series, FCW34 and FCW66 were shown to inhibit MDA-MB-231 cell migration as effectively as ST3GALIII-gene knockdown did. FCW34 was shown to inhibit tumor growth, reduce angiogenesis, and delay cancer cell metastasis in animal models. Furthermore, FCW34 inhibited vessel development and suppressed angiogenic activity in transgenic zebrafish models. Our results provide clear evidence that FCW34-induced sialyltransferase inhibition reduces cancer cell metastasis by decreasing N-glycan sialylation, thus altering the regulation of talin/integrin/FAK/paxillin and integrin/NFκB signaling pathways.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01477?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01477</a>.Effect of 2aA–2eA on migration in MDA-MB-231 cells; effect of FCW34 on migration in MDA-MB-231 cells; effect of FCW66 on migration in MDA-MB-231 cells; effects of ST3GALIII siRNA knockdown efficiency in MDA-MB-231 cells; inhibition of integrin sialylation by sialyltransferase inhibitors in MDA-MB-231 cells; effects of sialyltransferase inhibitor FCW34 on tumor metastasis in MDA-MB-231 breast cancer cells in vivo; effects of sialyltransferase inhibitor FCW34 on toxicity assessment in MDA-MB-231 breast cancer cells in vivo; effects of sialyltransferase inhibitors on the integrin–FAK–paxillin pathway in MDA-MB-231 cells; effects of sialyltransferase inhibitors on the NFκB pathway in MDA-MB-231 cells; apparent permeability (Papp) values obtained for the reference compounds, FCW34, and FCW66 using the PAMPA model; endogenous expression of ST6GALI, ST3GALIII, ST3GALI, and ST6GALNACI proteins; comparison of binding modes of 2aA–2eA, 3cB–3dB, 4cC–4dC, AL10, LCAG, and Lith-O-ASP in the binding sites of two asymmetric polypeptide chains (A/B) of ST6GALI (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QVT">6QVT</a>); computed physicochemical properties of the selected compounds used in this study; computational binding values of complex structure of ST6GALI-inhibitor; sensitization of tumors to ST inhibitors by regulation of the talin/integrin/FAK/paxillin and integrin/NFκB-signaling pathways; and experimental procedures, details of HPLC-determined purity data, HRMS results, and 1H and 13C NMR spectra of all final compounds and intermediates (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01477/suppl_file/jm0c01477_si_001.pdf">PDF</a>)Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01477/suppl_file/jm0c01477_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Synthesis and Evaluation of Trehalose‐Based Compounds As Novel Inhibitors of Cancer Cell Migration and Invasion

Synthesis and structure–activity relationships studies of brartemicin analogs as anti-invasive agents

Inhibition of invasion and metastasis by DMBT, a novel trehalose derivative, through Akt/GSK-3β/β-catenin pathway in B16BL6 cells.

The convenient aqueous synthesis and biological evaluation of ortho-(3,4,5-trimethoxybenzoyl)-acetanilides as novel anti-cancer agents

Discovery of tetrandrine derivatives as tumor migration, invasion and angiogenesis inhibitors

Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis

Synthesis and Preliminary Biological Evaluation of Novel Taspine Derivatives As Anticancer Agents.

Discovery of 18Β-Glycyrrhetinic Acid Conjugated Aminobenzothiazole Derivatives As Hsp90-Cdc37 Interaction Disruptors That Inhibit Cell Migration and Reverse Drug Resistance

Total Synthesis of Moscatilines and Wedelolactones As Potential Inhibitors of Anti-Metastic Agents in MDA-MB-231 Cells

Discovery of Novel Heteroarylmethylcarbamodithioates As Potent Anticancer Agents: Synthesis, Structure-Activity Relationship Analysis and Biological Evaluation.

Synthesis and Anti-tumor Activities of Novel 18Β-Glycyrrhetinic Acid Derivatives Attaching Dithiocarbamate Units

Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth.

Novel Myricetin Derivatives: Design, Synthesis and Anticancer Activity.

Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin‐Isatin Hybrids As Potent Anti‐Breast Cancer Agents

Modification of a natural diterpene and its antitumor mechanism: Promoting apoptosis, suppressing migration, and inhibiting angiogenesis

Synthesis and Antitumor Evaluation of Glycyrrhetinic Acid-Dithiocarbamate Hybrids.

Divergent De Novo Synthesis of 2,4,5-Trideoxyhexopyranosides Derivatives of Podophyllotoxin As Anticancer Agents.

Synthesis and Antiproliferative Activity of Novel 1,3,4-Thiadiazole Derivatives

Synthesis and cytotoxic studies of novel 5-phenylisatin derivatives and their anti-migration and anti-angiogenic evaluation.

Synthesis and biological evaluation of novel demethylzeylasteral derivatives as potential anticancer agents

Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.